Journals / Türk Kardiyoloji Derneği Arşivi / 2013 / Cilt: 41 - Sayı: 2

Anxiety levels and quality of life assessment in patients that underwent an electrophysiologic study due to unexplained palpitations

Açıklanamayan çarpıntı nedeniyle elektrofizyolojik çalışma yapılan hastalarda yaşam kalitesi ve kaygı düzeylerinin değerlendirilmesi

Pages
136–140
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In clinical practice it should be kept in mind that noticed psychiatric symptoms may be secondary to an underlying arrhythmia in the evaluation of patients with pal- pitations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To compare the quality of life and anxiety levels of patients with normal and abnormal results detected during an electrophysiological study (EPS) that was performed due to undocumented palpitations.
📊
Key Findings & Data:Study design: Patients (n=128) who underwent EPS with- out documented arrhythmia of unexplained palpitations were included in the study.
💡
Conclusion & Impact:In clinical practice it should be kept in mind that noticed psychiatric symptoms may be secondary to an underlying arrhythmia in the evaluation of patients with pal- pitations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To compare the quality of life and anxiety levels of patients with normal and abnormal results detected during an electrophysiological study (EPS) that was performed due to undocumented palpitations. Study design: Patients (n=128) who underwent EPS with- out documented arrhythmia of unexplained palpitations were included in the study. The quality of life and anxiety levels of patients with abnormal EPS results were compared with those with normal results by using the 26-item short form of the World Health Organization quality of life scale and state- trait anxiety inventory. Results: SVT was found in 72 patients by diagnostic EPS. Quality of life scores were significantly poorer in the SVT group than of the normal EPS group (p=0.000-0.001). Like- wise, the anxiety scores of the patients in the SVT group were higher than normal in the EPS group (p=0.000). Age, physical quality of life, psychological quality of life, state anxiety and trait anxiety were found to be independent predictors of SVT in multivariate regression analysis. Conclusion: The level of anxiety was found to be higher and quality of life was found to be lower in patients with palpita- tions due to SVT. In clinical practice it should be kept in mind that noticed psychiatric symptoms may be secondary to an underlying arrhythmia in the evaluation of patients with pal- pitations.

Özet

Amaç: Belgelenememiş çarpıntı atakları nedeniyle yapılan elektrofizyolojik çalışma (EFÇ) sonucu normal veya anormal olan hastaların yaşam kalitesi ve kaygı düzeyleri açısındankarşılaştırılması amaçlandı.Çalışma planı: Çalışmaya çarpıntı yakınması olan, aritmileri elektrokardiyografi (EKG) ile belgelenmemiş ve EFÇ yapılan 128 hasta alındı. EFÇ ile supraventriküler taşikardi (SVT) saptanan hastalar ile EFÇ sonucu normal olan hastalar Dünya Sağlık Örgütü yaşam kalitesi ölçeğinin 26 maddelik kısa formu ve durumluk-sürekli kaygı envanteri ile değerlendirilerek yaşam kalitesi ve kaygı düzeyi açısından karşılaştırıldı. Bulgular: Tanısal EFÇ işlemi sonucunda 72 hastada SVT saptandı. SVTli grubun yaşam kalitesi skorları EFÇleri normal grupdakilere göre anlamlı derecede daha kötü bulundu (p=0.000-0.001). Aynı şekilde SVTli hastalarda kaygı skorları da EFÇleri normal gruba göre daha yüksekti (p=0.000). Çok değişkenli regresyon analizinde yaş, bedensel alan yaşam kalitesi, ruhsal alan yaşam kalitesi, durumluk kaygı ve sürekli kaygı SVTnin bağımsız öngördürücüleri olarak bulundu.Sonuç: Çarpıntı yakınması SVTye bağlı olan hastalarda kaygı düzeyi daha yüksek ve yaşam kalitesi de daha düşük bulunmuştur. Klinik uygulamada çarpıntı yakınması olan hastalar değerlendirilirken fark edilen psikiyatrik semptomların altta yatan aritmiye sekonder olabileceği de göz önünde bulundurulmalıdır.

🔖

Cite This Article

ÖZTÜRK, S., ERDEM, A., CANAN, F., AYHAN, S. S., YAZICI, M., YILDIRIM, O., ÖZLÜ, M. F. (2022). Anxiety levels and quality of life assessment in patients that underwent an electrophysiologic study due to unexplained palpitations. Türk Kardiyoloji Derneği Arşivi, Cilt: 41 - Sayı: 2, 136–140. https://ajindex.com/articles/632972

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rundström H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 2004;36:674-9
  2. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18
  3. Birnie D, Williams K, Guo A, Mielniczuk L, Davis D, Lemery R, et al. Reasons for escalating pacemaker implants. Am J Cardiol 2006;98:93-7
  4. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, et al. Contemporary management of and outcomes from cardiac device related infections. Europace 2010;12:64-70
  5. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48:590-1
  6. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med 2005;118:1416
  7. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, et al. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-4
  8. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098-107
  9. Cetinkaya Y, Akova M, Akalin HE, Aşçioğlu S, Hayran M, Uzuns O, et al. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. Int J Antimicrob Agents 2001;18:1-7
  10. Leblebicioglu H, Yilmaz H, Tasova Y, Alp E, Saba R, Caylan R, et al. Characteristics and analysis of risk factors for mortality in infective endocarditis. Eur J Epidemiol 2006;21:25-31
  11. Sucu M, Davutoğlu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. Turk Kardiyol Dern Ars 2010;38:107-11
  12. Tuğcu A, Yildirimtürk O, Baytaroğlu C, Kurtoğlu H, Köse O, Sener M, et al. Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey. Turk Kardiyol Dern Ars 2009;37:9-18
  13. Erbay AR, Erbay A, Canga A, Keskin G, Sen N, Atak R, et al. Risk factors for in-hospital mortality in infective endocarditis: five years’ experience at a tertiary care hospital in Turkey. J Heart Valve Dis 2010;19:216-24
  14. İnanç T, Kaya MG, Kaya EG, Doğan A, Ardıç İ, Doğdu O, ark. İnfektif